Motivated behaviors, included those altered in substance use disorders, are known to be regulated by monoaminergic circuits (containing neurons that release dopamine, serotonin, and norepinephrine) in multiple brain regions. Disentangling these circuits from the cell-level to the systems- and behavioral-levels has almost exclusively been limited to studying the physiology of neurons. However, recent data suggest that the activity of a non-neuronal cell type?astrocytes?may have profound effects on how monoaminergic networks function, but how astrocytes respond to monoamines and change their physiology in response to repetitive drug exposure remain almost completely unstudied. The current proposal aims to address gaps in our understanding of addiction, monoamine signaling, and multi-cell type population dynamics by uncovering fundamental cell biological signaling systems in astrocytes that are critical for the function of brain regions with monoaminergic input.
In Aim 1, we will use two-photon imaging and photoactivation to interrogate the cell signaling mechanisms that prefrontal cortical astrocytes deploy to sense extracellular monoamine dynamics across cortical layers.
In Aim 2, we will decode the mechanisms by which astrocytes change, both instrinsically and in their output to the neuronal population, after long-term exposure to a psychostimulant. With these aims, we will probe the roles of astrocyte physiology in baseline prefrontal cortex function and as mediators of circuit neuroplasticity in a model of addiction.

Public Health Relevance

The monoaminergic neuromodulators (dopamine, serotonin, and norepinephrine) are critical in mediating animal behaviors, including those related to reward, learning, motivation, and addiction, but most research into monoaminergic circuits only focuses on the activity of neurons. In this proposal, we focus on the role that astrocytes?the most abundant non-neuronal cell type in the brain?play in monoaminergic signaling in the prefrontal cortex, both at baseline and after a pyschostimulant sensitization protocol. Together, these results will lay the groundwork for in-depth examinations of astrocytic involvement in monoaminergic signal processing across brain regions and behaviors, particularly those related to addiction.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DA048497-02
Application #
9912149
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Berton, Olivier Roland
Project Start
2019-04-15
Project End
2021-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Biochemistry
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118